HMGCR and cardiovascular disorder: Statins inhibit 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (HMGCR), effectively lowering low-density lipoprotein cholesterol (LDL-C) levels [4], and are widely prescribed for the prevention and management of cardiovascular diseases [5].